Evotec's expertise in medicinal chemistry has enabled it to carry out more than 200 collaborations with leading Pharmaceutical and Biotechnology companies.
Evotec has a broad therapeutic knowledge and as a result our scientists are named inventors on more than 100 medicinal chemistry patent applications encompassing many therapeutic areas and a variety of target classes including kinases, GPCRs and ion channels.

"Evotec is much more than an outsourcing partner to us. Their understanding of the drug discovery, biology processes and experienced consultancy compliment our biology and understanding of the genetics of ageing. In just over a year they (Evotec) have delivered a number of validated lead series and we firmly believe that the partnership has saved us overall two years in development."
Peter DiStefano, Ph.D., Chief Scientific Officer, Elixir Pharmaceuticals